Feasibility  Double-blindDTPa-HBV-IPV/HIB-MenC control : DTPa-HBV-IPV + HiberixLot D21798A2;D21799B2;DCH002A46;DCH003A46;Hib400A47/MInfants 2-3 months
Meningococcal Serogroups A, C, W-135 and Y Vaccine
Infections, Meningococcal
Phase 2
A follow on study 404286/006 was conducted. There is no GSK Clinical Study Register record for this study . A link to and a NCT ID number are not available for this study because the study is not in scope of regulatory requirements to register studies. An annotated case report form is not available for this study. A blank case report form will be provided.
February 2016